Dr. Herbert Engelhard discusses a newly FDA-approved brain tumor treatment
Posted: January 04, 2012 by Sherri McGinnis Gonzalez
WGN-TV's Medical Watch segment at 9 p.m. tonight (1/4/12) will feature Dr. Herbert Engelhard, chief of neuro-oncology at the University of Illinois Hospital, and patient David Messmer who is the first person in the country to receive a newly FDA-approved brain tumor treatment. The hospital is one of the first centers in the U.S. to receive training and certification to treat patients with recurrent glioblastoma multiforme, or GBM, with a new therapy called Tumor Treating Fields. This novel, non-invasive therapy is provided using a portable device which uses alternating electrical fields to disrupt the rapid cell division exhibited by cancer cells.
The interview is available online at: http://www.wgntv.com/videogallery/67164967/Health/Novocure-Treatment-for-Glioblastoma
Sherri McGinnis González
Associate Director, News Bureau
Office of Public Affairs
University of Illinois at Chicago
(312) 996-8277 phone
(312) 413-1883 fax
smcginn@uic.edu
Visit www.news.uic.edu
Follow @smcginnuic on Twitter
